As diabetes care continues to be a significant focus, new treatments are emerging . Retatrutide, Tirzepatide, and Semaglutide represent a exciting evolution in incretin mimetic medications. While all work to https://directmysocial.com/story6956210/retatrutid-vs-tirzepatid-vs-semaglutide-a-direct-analysis